Standard Chemical Financials

1720 Stock  TWD 62.80  0.30  0.48%   
Financial data analysis helps to confirm if markets are presently mispricing Standard Chemical. We are able to interpolate and break down thirty-six available drivers for Standard Chemical Pharmaceutical, which can be compared to its competition. The stock experiences a normal upward fluctuation. Check odds of Standard Chemical to be traded at NT$65.94 in 90 days.
  
Understanding current and past Standard Chemical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Standard Chemical's financial statements are interrelated, with each one affecting the others. For example, an increase in Standard Chemical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Standard Chemical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Standard Chemical Pharmaceutical. Check Standard Chemical's Beneish M Score to see the likelihood of Standard Chemical's management manipulating its earnings.

Standard Chemical Stock Summary

Standard Chemical competes with Sinphar Pharmaceutical, Grape King, Apex Biotechnology, and Maywufa. Standard Chem Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products in Taiwan and internationally. The company was founded in 1967 and is headquartered in Tainan City, Taiwan. STANDARD CHEM operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
InstrumentTaiwan Stock View All
ExchangeTaiwan Stock Exchange
ISINTW0001720001
Business AddressNo 6-20, Tuku,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.standard.com.tw
Phone886 6 636 1511
CurrencyTWD - New Taiwan Dollar
You should never invest in Standard Chemical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Standard Stock, because this is throwing your money away. Analyzing the key information contained in Standard Chemical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Standard Chemical Key Financial Ratios

There are many critical financial ratios that Standard Chemical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Standard Chemical reports annually and quarterly.

Standard Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Standard Chemical's current stock value. Our valuation model uses many indicators to compare Standard Chemical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Standard Chemical competition to find correlations between indicators driving Standard Chemical's intrinsic value. More Info.
Standard Chemical Pharmaceutical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.38  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Standard Chemical Pharmaceutical is roughly  2.60 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Standard Chemical's earnings, one of the primary drivers of an investment's value.

Standard Chemical Systematic Risk

Standard Chemical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Standard Chemical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Standard Chemical correlated with the market. If Beta is less than 0 Standard Chemical generally moves in the opposite direction as compared to the market. If Standard Chemical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Standard Chemical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Standard Chemical is generally in the same direction as the market. If Beta > 1 Standard Chemical moves generally in the same direction as, but more than the movement of the benchmark.

Standard Chemical Thematic Clasifications

Standard Chemical Pharmaceutical is part of Synthetics investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Synthetics production and silicon. Companies involved in production of silicon and other synthetic products
SyntheticsView
This theme covers Synthetics production and silicon. Companies involved in production of silicon and other synthetic products . Get More Thematic Ideas

Standard Chemical March 1, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Standard Chemical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Standard Chemical Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Standard Chemical Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Standard Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Standard Chemical's daily price indicators and compare them against related drivers.

Additional Tools for Standard Stock Analysis

When running Standard Chemical's price analysis, check to measure Standard Chemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Chemical is operating at the current time. Most of Standard Chemical's value examination focuses on studying past and present price action to predict the probability of Standard Chemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Chemical's price. Additionally, you may evaluate how the addition of Standard Chemical to your portfolios can decrease your overall portfolio volatility.